Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Purpose Detection of specific molecular alterations in tumors guides the selection of effective targeted treatment of patients with several types of cancer. These molecular alterations may occur in other tumor types for which the efficacy of targeted therapy remains unclear. The MyPathway study eval...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 36; no. 6; p. 536
Main Authors:	Hainsworth, John D, Meric-Bernstam, Funda, Swanton, Charles, Hurwitz, Herbert, Spigel, David R, Sweeney, Christopher, Burris, Howard, Bose, Ron, Yoo, Bongin, Stein, Alisha, Beattie, Mary, Kurzrock, Razelle
Format:	Journal Article
Language:	English
Published:	United States 20.02.2018
Subjects:	Adult Aged Aged, 80 and over ErbB Receptors - antagonists & inhibitors ErbB Receptors - genetics Female Hedgehog Proteins - antagonists & inhibitors Humans Male Middle Aged Molecular Targeted Therapy - methods Mutation Neoplasms - drug therapy Neoplasms - genetics Proto-Oncogene Proteins B-raf - antagonists & inhibitors Proto-Oncogene Proteins B-raf - genetics Receptor, ErbB-2 - antagonists & inhibitors Receptor, ErbB-2 - genetics
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!